During the past decade, ResEvo LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ResEvo LLC" #1 collaborator was "Ionis Pharmaceuticals, Inc." with 1 trials as a collaborator and "University of Kentucky" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "ResEvo LLC" are "Coronary Artery Disease" (1 trials), "Heterozygous Familial Hypercholesterolemia" (1 trials), "Type 2 Diabetes" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "ResEvo LLC" in a lesser frequency.

Most popular intervention types in "ResEvo LLC" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "INT131 besylate" (1 trials), "Pioglitazone HCl" (1 trials), "Placebo" (1 trials), "Sugar Substitute Splenda" (1 trials) and "Tagatose" (1 trials). Other intervention names were less common.

The vast majority of trials in "ResEvo LLC" are 3 trials for "All" genders.

Currently, there are NaN active trials in "ResEvo LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ResEvo LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ResEvo LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".